❌

Normal view

  • βœ‡STAT
  • STAT+: $775 billion, $1.2 billion, and $38k Bob Herman
    This is the online version of STAT’s weekly email newsletter Health Care Inc.Β Sign up here. Hello, diligent HCI readers! I hope everyone enjoyed their Memorial Day weekends. We’ve got a lot of numbers in today’s edition. Get out your abacus. And tell me if you want more or less math in here: bob.herman@statnews.com. $775 billion Centers for Medicare and Medicaid Services Republicans’ recent tax law targets supplemental Medicaid funds that have increasingly propped up hospitals.
     

STAT+: $775 billion, $1.2 billion, and $38k

27 May 2026 at 00:11

This is the online version of STAT’s weekly email newsletter Health Care Inc.Β Sign up here.

Hello, diligent HCI readers! I hope everyone enjoyed their Memorial Day weekends. We’ve got a lot of numbers in today’s edition. Get out your abacus. And tell me if you want more or less math in here: bob.herman@statnews.com.

$775 billion

Centers for Medicare and Medicaid Services

Republicans’ recent tax law targets supplemental Medicaid funds that have increasingly propped up hospitals. The cuts are expected to be even bigger than originally forecast, which almost assuredly will provoke an opposition campaign from hospitals.

Continue to STAT+ to read the full story…

Β© Adobe

  • βœ‡STAT
  • STAT+: Five biotech news updates to stay on top of today Meghana Keshavan
    Want to stay on top of the science and politics driving biotech today?Β Sign upΒ to get our biotech newsletter in your inbox. Hi! Hope you had a nice extended weekend. Today: Eli Lilly’s gene-editing data seems promising for high cholesterol, an AI drug discovery CEO dispelled some AI drug discovery hype, and the new interim FDA chief is so far well received.Continue to STAT+ to read the full story…
     

STAT+: Five biotech news updates to stay on top of today

26 May 2026 at 21:50

Want to stay on top of the science and politics driving biotech today?Β Sign upΒ to get our biotech newsletter in your inbox.

Hi! Hope you had a nice extended weekend.

Today: Eli Lilly’s gene-editing data seems promising for high cholesterol, an AI drug discovery CEO dispelled some AI drug discovery hype, and the new interim FDA chief is so far well received.

Continue to STAT+ to read the full story…

Β© Adobe

InfoQ Online Certification Program: New AI Engineering and Organizational Architecture Cohorts

26 May 2026 at 18:00

InfoQ expands its online certification portfolio with new AI Engineering and Organizational Architecture cohorts, giving senior practitioners a confidential peer group to pressure-test production AI, platform, team design, and architecture decisions.

By Artenisa Chatziou

Article: Architecting Cloud-Native Kafka: From Tiered Storage Towards a Diskless Future

26 May 2026 at 17:00

This article explores Kafka's transition toward a cloud-native architecture, examining how tiered storage, FinOps telemetry, elastic consumer scaling, virtual clusters, and Share Groups reshape the operational and economic model of event streaming platforms. It also analyzes emerging diskless-storage proposals and their architectural trade-offs.

By Viquar Khan

Google Expands SynthID Adoption for AI Watermarking, Previews Content Detection API

26 May 2026 at 17:00

Google's SynthID, designed to embed imperceptible signals into AI-generated content, is adding a new Content Detection API on Google Cloud's Gemini Enterprise Agent Platform, after gaining adoption by several industry players including Nvidia and OpenAI.

By Sergio De Simone
  • βœ‡InfoQ
  • TamboUI Promises to Bring Better Capabilities to Build TUIs in Java Olimpiu Pop
    The call to action β€œto make 2026 the year of Java in the terminal” was quickly responded to by the launch of TamboUI. Inspired by Ratatui, the library used in Claude CLI, it promises support ranging from low-level terminal drawing to high-level APIs such as components and event handling. Currently at version 0.3.0, it has already been adopted by major projects such as Maven and Spring. By Olimpiu Pop
     

TamboUI Promises to Bring Better Capabilities to Build TUIs in Java

26 May 2026 at 17:00

The call to action β€œto make 2026 the year of Java in the terminal” was quickly responded to by the launch of TamboUI. Inspired by Ratatui, the library used in Claude CLI, it promises support ranging from low-level terminal drawing to high-level APIs such as components and event handling. Currently at version 0.3.0, it has already been adopted by major projects such as Maven and Spring.

By Olimpiu Pop
  • βœ‡STAT
  • STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA Lizzy Lawrence
    WASHINGTON β€” People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025.Β  They knew Kyle Diamantas worked at Jones Day representing food, beverage, and tobacco-industry clients. They saw the picture of him and Donald Trump Jr. holding giant, dead wild turkeys after a hunt. He had no experience in public health, in medicine or science, or in government. The credentials didn’t scream quali
     

STAT+: How Kyle Diamantas defied expectations as he rose to lead the FDA

26 May 2026 at 16:30

WASHINGTON β€” People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney as the FDA’s top food official in 2025.Β 

They knew Kyle Diamantas worked at Jones Day representing food, beverage, and tobacco-industry clients. They saw the picture of him and Donald Trump Jr. holding giant, dead wild turkeys after a hunt. He had no experience in public health, in medicine or science, or in government.

The credentials didn’t scream qualified. And Diamantas was stepping into a center rocked by DOGE layoffs and a defiant resignation by former leader Jim Jones.Β 

Continue to STAT+ to read the full story…

Β© Camille MacMillin/STAT

Java News Roundup: WildFly, Micronaut, Spring AI, Apache Fory, GlassFish Plugin, Open Liberty

26 May 2026 at 10:30

This week's Java roundup for May 18th, 2026, features news highlighting: GA releases of WildFly 40, Micronaut 5.0, Maven Embedded GlassFish Plugin 8.0 and Apache Fory 1.0; the May 2026 edition of Open Liberty; point releases of Gatherers4j, Apache and Kafka; and the seventh milestone release of Spring AI 2.0.

By Michael Redlich
  • βœ‡InfoQ
  • Article: The Schema Proliferation Problem in Kafka and Flink Pipelines: How to Solve It Spoorthi Basu
    Schema proliferation builds slowly and gets expensive fast. One schema per event type feels right until there are ten tables, union queries spanning all of them, and a single field rename touching every schema. Discriminator-based schema consolidation collapses that to two tables, turning multi-table unions into a single query, while new variants are additive and don't break existing consumers. By Spoorthi Basu
     

Article: The Schema Proliferation Problem in Kafka and Flink Pipelines: How to Solve It

25 May 2026 at 21:00

Schema proliferation builds slowly and gets expensive fast. One schema per event type feels right until there are ten tables, union queries spanning all of them, and a single field rename touching every schema. Discriminator-based schema consolidation collapses that to two tables, turning multi-table unions into a single query, while new variants are additive and don't break existing consumers.

By Spoorthi Basu

Podcast: Chasing Efficient Java Development: From 1BRC to Developing Hardwood AI Natively

25 May 2026 at 19:00

Gunnar Morling, technologist at Confluent and Java Champion, shares his experiences with building high-performance applications in Java, especially in the data space. He shares insights from experiments with building durable execution engines, bootstrapping, and AI natively developing Apache Hardwood - a minimal dependencies Java parser for Apache Parquet.

By Gunnar Morling

Gemma 4 Multi-Token Prediction Delivers up to ~3x Faster Token Generation

25 May 2026 at 17:00

Gemma 4 can be paired with multi-token prediction (MTP) drafters that use speculative decoding to generate multiple tokens in parallel, allowing the model to verify them in a single pass and achieve up to ~3Γƒβ€” faster inference without quality loss.

By Sergio De Simone

NodeJS Proposes Built-In Virtual File System, Sparking Debate over AI-Generated Contributions

25 May 2026 at 14:24

Matteo Collina has proposed a Virtual File System (VFS) for Node.js core through the node:vfs module. The proposal includes about 19,000 lines of code and addresses common workflow challenges. While it has community support, concerns have arisen regarding the use of AI in its development, prompting debates about its implications for code verification and necessity in the Node.js ecosystem.

By Daniel Curtis

OpenJDK News Roundup: Vector API, Compact Object Headers and G1GC as Default in JDK 27

25 May 2026 at 10:30

There was a flurry of activity in the OpenJDK ecosystem during the week of May 18th, 2026, highlighting three JEPs elevated from Proposed to Target to Targeted and three JEPs elevated from Candidate to Proposed to Target for JDK 27. The proposed release schedule has also been finalized.

By Michael Redlich
  • βœ‡STAT
  • STAT+: EU and US advisers split over AstraZeneca breast cancer drugΒ  Meghana Keshavan
    Want to stay on top of the science and politics driving biotech today?Β Sign upΒ to get our biotech newsletter in your inbox. Merck’s bet on an antibody-drug conjugate developed in China has paid off in a major Phase 3 lung cancer study, where sacituzumab tirumotecan paired with Keytruda sharply outperformed Keytruda alone in a subset of lung cancer patients. Also, the NIH is down another leader, and Sam Altman-backed longevity startup Retro Biosciences raises more funds.Continue to STAT+ to
     

STAT+: EU and US advisers split over AstraZeneca breast cancer drugΒ 

22 May 2026 at 21:40

Want to stay on top of the science and politics driving biotech today?Β Sign upΒ to get our biotech newsletter in your inbox.

Merck’s bet on an antibody-drug conjugate developed in China has paid off in a major Phase 3 lung cancer study, where sacituzumab tirumotecan paired with Keytruda sharply outperformed Keytruda alone in a subset of lung cancer patients.

Also, the NIH is down another leader, and Sam Altman-backed longevity startup Retro Biosciences raises more funds.

Continue to STAT+ to read the full story…

Β© Adobe

❌